Nombre del producto:[1,2,4]Triazolo[4,3-a]quinoxalin-4(5H)-one

IUPAC Name:4H,5H-[1,2,4]triazolo[4,3-a]quinoxalin-4-one

CAS:91895-36-2
Fórmula molecular:C9H6N4O
Pureza:95%+
Número de catálogo:CM374420
Peso molecular:186.17

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :91895-36-2
Fórmula molecular:C9H6N4O
Punto de fusión:-
Código de sonrisas:O=C1NC2=C(C=CC=C2)N2C=NN=C12
Densidad:
Número de catálogo:CM374420
Peso molecular:186.17
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Pyrazines
Pyrazine is a heterocyclic aromatic organic compound with chemical formula C4H4N2. The marketed pyrazine drugs are mainly distributed in the field of anti-tumor and anti-infection. In recent years, there have been many new drugs in various fields, and there are some new target drugs worthy of attention.
pyrazine,pyrazine price
if you want to know the latest news about pyrazine and pyrazine price, please come to our website and get a quote for free.
Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.
Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.